OTC · Medical - Devices

Broncus Holding Corporation (BRNHF) Stock

$0.08 +0.00% OTC: BRNHF Healthcare

Broncus Holding Corporation is a medical technology enterprise dedicated to advancing interventional pulmonology through the development of specialized products. Its operational reach extends across key markets including Mainland China, the European Union, the United States, and other international regions.

Valuation

MetricValue
Price$0.08
Market Cap$42.13M
P/E Ratio-2.21
P/B Ratio0.26
P/S Ratio246.68
EPS (TTM)$-0.04
52-Week High$0.08
52-Week Low$0.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-11.54%
ROA-11.47%
ROCE-16.26%
Gross Margin—
Operating Margin—
Net Margin—
Debt/Equity0.00
Current Ratio22.70

Annual Financials (USD)

Metric20212022202320242025
Revenue$11.0M$9.0M$10.0M$8.0M$0
Operating Profit$-35.0M$-33.0M$-33.0M$-20.0M$-24.0M
Net Profit$-235.0M$-28.0M$-28.0M$-15.0M$-18.0M
EPS$-0.45$-0.06$-0.06$-0.03$-0.04
Op Margin-320.4%-347.5%-323.9%-243.4%-14017.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$253.0M$222.0M$196.0M$176.0M$156.0M
Total Liabilities$10.0M$8.0M$10.0M$6.0M$6.0M
Cash$227.0M$107.0M$84.0M$46.0M$32.0M
Borrowings$2.0M$1.0M$2.0M$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-32.0M$-31.0M$-26.0M$-10.0M$-10.0M
Investing Cash Flow$-4.0M$-89.0M$5.0M$-26.0M$-1.0M
Financing Cash Flow$0$-1.0M$-1.0M$-1.0M$-5.0M
Net Cash Flow$208.0M$-120.0M$-23.0M$-37.0M$-15.0M
Free Cash Flow$-34.0M$-32.0M$-27.0M$-10.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.12
EV / EBITDA-0.49
FCF Yield-23.35%
Quick Ratio22.04
Interest Coverage-6097.78
Return 1Y0.00%
Return 3Y-73.94%
Return 5Y—

Ownership

Insiders Held8.88%
Institutions Held29.20%
Institutions Float Held32.05%
Institutional HolderSharesReport Date
SPDR INDEX SHARES Fd.S-State Street SPDR S&P Emerging Markets Small Ca403,0002026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADOCYAdocia S.A. $11.80 +0.00% -3.91 $170.44M 0.00%
AMCYACS Global, Inc. $3.00 -40.00% — $171.27M 0.00%
AMEUFAnteris Technologies Ltd $5.70 -35.81% -3.37 $120.50M 0.00%
CKMTFCarmat S.A. $12.75 -50.96% -0.04 $85.19M 0.00%
CMXCCell MedX Corp. $0.43 — -11.01 $126.33M 0.00%

About Broncus Holding Corporation

Broncus Holding Corporation is a medical technology enterprise dedicated to advancing interventional pulmonology through the development of specialized products. Its operational reach extends across key markets including Mainland China, the European Union, the United States, and other international regions. The company's product portfolio is broadly categorized into navigation and treatment solutions. Navigation offerings include: LungPoint Virtual Bronchoscopic Navigation: A sophisticated, computer-assisted software system that utilizes imaging for virtual bronchoscopic guidance. LungPoint Plus: This system provides real-time navigational assistance within the airways, crucial for lung biopsies and various other pulmonological procedures. LungPro: A virtual bronchoscopic navigation tool that facilitates three-dimensional, real-time guided transbronchial needle aspiration and features proprietary parenchymal navigation capabilities. Its comprehensive suite of treatment products comprises: InterVapor: A targeted bronchoscopic thermal vapor ablation method designed to treat diseased, hyper-inflated lung segments. RF Generator + RF Ablation Catheter: A radiofrequency ablation system specifically engineered for use with a disposable lung radiofrequency ablation catheter, targeting lung cancer. H-Marker: A specialized marker for pulmonary surgical applications. Furthermore, Broncus provides essential procedural accessories and tools such as: BioStarNeedle: A single-use, ultrasound-guided aspiration needle for efficiently collecting tissue samples. FleXNeedle: A versatile biopsy needle adaptable for multiple purposes. Archimedes Sheath: A sterile, single-use flexible tube that establishes a working channel during bronchoscopic interventions. Archimedes Dilation Balloon: A sterile, single-use flexible tube equipped with a balloon at its tip, inserted via a bronchoscope or sheath to dilate targeted lung tissue within the bronchial tree. Steerable Sheath: Featuring a steerable adjustment handle and a working channel for enhanced maneuverability. Broncus Holding Corporation was established in 2012 and maintains its corporate headquarters in Hangzhou, China.

Broncus Holding Corporation is headquartered in CN.

Broncus Holding Corporation (BRNHF) stock trades at $0.08 with a market capitalization of $42.13M. The stock is valued at a price-to-earnings (P/E) ratio of -2.21, price-to-book of 0.26, price-to-sales of 246.68. Over the past 52 weeks the stock has ranged between $0.08 and $0.08, and currently trades at its 52-week high.

On profitability, Broncus Holding Corporation generates a return on equity (ROE) of -11.54%, return on capital employed of -16.26%.

Official website: www.broncus.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides